The EBITDA Normalisation Trap: How Unexamined Principal Add-Backs Distort Middle-Market Valuations

Aggressive EBITDA normalisations do not increase enterprise value; they expand the buyer's perceived risk profile and shift deal structure from cash-at-completion to punitive earn-outs and indemnity escrows. Graham Chee, FCPA, CPA, principal of Local Knowledge, writes from a practice that pairs FCPA-grade compliance with Goldman Sachs, BNP Investment Management and Merrill Lynch institutional experience to demonstrate how unvetted owner add-backs destroy transactional credibility. In the Australian middle market, private equity buyers and institutional acquirers scrutinise quality of earnings through a forensic lens Sydney accounting specialists. When discretionary personal expenses, non-market owner remuneration, and non-arm's length related-party leases are improperly added back without statutory substantiation, the headline valuation collapses during confirmatory due diligence, permanently impairing deal leverage.

Consider a Sydney-based precision manufacturing firm with reported statutory EBITDA of $3.2 million. In preparing for sale, the owner-advisor team introduces $1.1 million in proposed add-backs: $450,000 in director discretionary distributions, $250,000 in non-recurring litigation and factory consolidation expenses, and $400,000 for below-market commercial property rent paid to an associate entity. The business is taken to market on an adjusted EBITDA base of $4.3 million seeking a 6.0x multiple, targeting a $25.8 million enterprise value.

During confirmatory financial due diligence, institutional buy-side accountants interrogate these normalisations against real market parameters. Replacement executive search benchmarks demonstrate that replacing the founder requires a qualified CEO package of $350,000 plus statutory superannuation, reducing the owner compensation add-back to under $100,000. An independent valuation reveals the industrial premises was leased at 40% below market rates, requiring an earnings deduction rather than an addition financial structuring and corporate monetization strategies. Finally, the litigation costs are proved to be part of ongoing IP defence normal in the industry. The verified EBITDA is revised downward to $3.1 million. The buyer does not simply reduce the purchase price to $18.6 million; they perceive an earnings quality governance risk, slashing the enterprise multiple to 4.8x and demanding a 30% retention escrow against future representations and warranties.